Entity
  • cellvie

    Created in 2018
  • BETA

    Up & running (A)
    Existing signals show a regular activity
  • Social networks

    2,997
  • Activities

  • Technologies

  • Entity types

  • Location

    Zurich, Switzerland

    Zuerich

    Switzerland

  • Employees

    Scale: 2-10

    Estimated: 11

  • Engaged corporates

    2
    0 2
  • Added in Motherbase

    9 months ago
Description
  • Value proposition

    Levearging the therapeutic potential of mitochondria

    cellvie is the leader in Therapeutic Mitochondria Transplantation (TMT).

    The team is seeking to bring about a novel treatment modality, leveraging the therapeutic potential of mitochondria, the powerhouses of the cell.

    Therapeutic Mitochondria Transplantation, an approach for mitochondria augmentation and replacement, was developed by Dr. James McCully at Harvard Medical School. cellvie was founded to take this technology from bench to bed, starting in heart attacks and solid organ transplantation.

    Therapeutic Mitochondria Transfer, Mitochondria, Ischemia-Reperfusion Injury, and Solid Organ Transplantation

  • Home - cellvie Inc.

    At cellvie, we are pioneering Therapeutic Mitochondria Transplantation, a novel treatment approach aimed at the cellular energy metabolism.

  • https://cellvie.bio/
Corporate interactions BETA
Corporate TypeTweets Articles
GSK
GSK
Pharmaceutical, Pharmaceutical Manufacturing
GSK
Pharmaceutical, Pharmaceutical Manufacturing
Other

30 Apr 2023


Novartis
Novartis
Pharmaceutical, Pharmaceutical Manufacturing
Novartis
Pharmaceutical, Pharmaceutical Manufacturing
Other

30 Apr 2023


Similar entities
Loading...
Loading...
Social network dynamics